Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Xetra  >  Fresenius SE & Co. KGaA    FRE   DE0005785604

FRESENIUS SE & CO. KGAA

(FRE)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Business Summary
Logo Fresenius SE & Co. KGaA
Fresenius specializes in designing, producing, and selling medical drugs, equipment, and devices used in clinical hospitalization and at home. Net sales break down by activity as follows:

- dialysis treatment (49%; Fresenius Medical Care): sales of equipment for hemodialysis, pediatric dialysis, peritoneal dialysis, dialysis services, etc.;

- hospital administration and engineering (31.6%; Fresenius Vamed and Fresenius Helios): management of technical facilities and medical equipment, hospital management, design and production of medical equipment for the pharmaceutical sector, etc.;

- perfusion and clinical nutrition (19.4%; Fresenius Kabi): sales of parenteral and oral nutrition products, perfusion and vascular filling equipment, transfusion materials, generic injectable products, home medical assistance services in the areas of perfusion, nutrition, and oxygen therapy, etc.

Net sales are distributed geographically as follows: Europe (43.2%), North America (41.4%), Asia/Pacific (10%), Latin America (4.1%) and Africa (1.3%).
Sales per Businesses
20172018Delta
EUR (in Million)%EUR (in Million)%
Fresenius Medical Care17,75452.4%16,51549.3% -6.98%
Fresenius Helios8,65225.5%8,98326.8% +3.83%
Fresenius Kabi6,30118.6%6,48919.4% +2.98%
Fresenius Vamed1,1743.5%1,5414.6% +31.26%
Corporate/Other5.000%2.000% -60%
Sales per Regions
20172018Delta
EUR (in Million)%EUR (in Million)%
North America15,09344.5%13,86141.3% -8.16%
Europe13,76740.6%14,48443.2% +5.21%
Asia Pacific3,1829.4%3,36610% +5.78%
Latin America1,4314.2%1,3874.1% -3.07%
Africa413.001.2%432.001.3% +4.6%
Managers
NameAgeSinceTitle
Stephan Sturm562016President & Chief Executive Officer
Gerd Krick812003Chairman-Supervisory Board
Rachel Clare Empey432017Chief Financial Officer
Niko Stumpfögger642007Deputy Chairman-Supervisory Board
Klaus-Peter Müller752008Member-Supervisory Board
Michael Albrecht, Dr.702011Member-Supervisory Board
Konrad Kölbl602007Member-Supervisory Board
Michael Diekmann652015Deputy Chairman-Supervisory Board
Hauke Stars522016Member-Supervisory Board
Iris Löw-Friedrich, Dr.592016Member-Supervisory Board
Equities
Vote QuantityFloatCompany-owned sharesTotal Float
Stock A 1 557,201,495 418,102,699 75.0% 0 0.0% 75.0%
Shareholders
NameEquities%
Else Kröner-Fresenius-Stiftung 146,261,594 26.2%
Allianz Global Investors GmbH 28,373,960 5.09%
DWS Investment GmbH 13,138,026 2.36%
The Vanguard Group, Inc. 12,070,434 2.17%
Capital Research & Management Co. (World Investors) 11,352,226 2.04%
Norges Bank Investment Management 9,383,502 1.68%
BlackRock Fund Advisors 7,156,865 1.28%
DWS Investments (UK) Ltd. 6,290,505 1.13%
Lyxor International Asset Management SAS 6,254,328 1.12%
Deka Investment GmbH 5,939,181 1.07%
Holdings
NameEquities%Valuation
Fresenius Medical Care AG & Co. KGaA (FME) 94,380,38231.0%7,290,086,051 USD
Cupid Ltd (530843) 360,0002.70%1,110,661 USD
Markets and indexes
- Börse Frankfurt
- Prime Standard
- DAX 30 / Euro Stoxx 50
Stock Exchange Codes
- Bloomberg Code :  FRE:GR
- Reuters Code :  FREG.DE
- Datastream Code :  D:FRE
Company contact information
Fresenius SE & Co. KGaA
Else-Kröner-Strasse 1
DE-61352 Bad Homburg vor der Höhe, Hessen
Germany

Phone : +49 (0) 6172 608 0
Fax : +49
Internet : http://www.fresenius-ag.com
Brand Portfolio
In partnership withAllbrands.markets
More brands of Fresenius SE & Co. KGaA
Connections : Fresenius SE & Co. KGaA